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Abstract
Background: HIV-, HCV- and HIV/HCV co-infections among drug users have become a rapidly emerging global
public health problem. In order to constrain the dual epidemics of HIV/AIDS and drug use, China has adopted a
methadone maintenance treatment program (MMTP) since 2004. Studies of the geographic heterogeneity of HIV
and HCV infections at a local scale are sparse, which has critical implications for future MMTP implementation and
health policies covering both HIV and HCV prevention among drug users in China. This study aimed to characterize
geographic patterns of HIV and HCV prevalence at the township level among drug users in a Yi Autonomous
Prefecture, Southwest of China.
Methods: Data on demographic and clinical characteristics of all clients in the 11 MMTP clinics of the Yi
Autonomous Prefecture from March 2004 to December 2012 were collected. A GIS-based geographic analysis
involving geographic autocorrelation analysis and geographic scan statistics were employed to identify the
geographic distribution pattern of HIV-, HCV- and co-infections among drug users.
Results: A total of 6690 MMTP clients was analyzed. The prevalence of HIV-, HCV- and co-infections were 25.2%,
30.8%, and 10.9% respectively. There were significant global and local geographic autocorrelations for HIV-, HCV-,
and co-infection. The Moran’s I was 0.3015, 0.3449, and 0.3155, respectively (P < 0.0001). Both the geographic
autocorrelation analysis and the geographic scan statistical analysis showed that HIV-, HCV-, and co-infections in the
prefecture exhibited significant geographic clustering at the township level. The geographic distribution pattern of
each infection group was different.
Conclusion: HIV-, HCV-, and co-infections among drug users in the Yi Autonomous Prefecture all exhibited
substantial geographic heterogeneity at the township level. The geographic distribution patterns of the three
groups were different. These findings imply that it may be necessary to inform or invent site-specific intervention
strategies to better devote currently limited resource to combat these two viruses.
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Background
Human immunodeficiency virus (HIV) infection and
hepatitis C virus (HCV) infection are major public health
problems worldwide. More than 34 million persons cur-
rently live with HIV/AIDS and 170 million people may be
infected with HCV [1-3]. By the end of 2011, China had
an estimated 780,000 (620,000-940,000) people living with
HIV/AIDS including 154,000 (146,000-162,000) AIDS
cases. 28.4% of the 780,000 persons were infected from
intravenous drug use [4]. In 2011, an estimated 48,000
individuals were newly infected with HIV, and in the same
year 28,000 people died from AIDS [4]. As HIV and HCV
share similar routes of transmission, including blood-
blood contact, injected drug use, and sexual contact, co-
infection with HIV and HCV is very common. Intravenous
drug users (IDUs) often share contaminated needles or
syringes for intravenous drug injection [1-3,5-7]. It has
been estimated that 25% of people infected with HIV in
the United States are also infected with HCV. The
reported prevalence of co-infection with HIV and HCV
is above 90% among IDUs [5,8,9]. The accelerated liver
disease found in HCV patients leads to increased
morbidity and mortality in the HIV/AIDS patients. Co-
infected patients bear a significant proportion of the
mortality [1].
In China, there are approximately 2.4 million IDUs,
the world’s largest population of IDUs. The proportion
of IDUs living with HIV/AIDS is high [10]. In 1989, the
first HIV outbreak in China appeared among IDUs from
Southwest China. This has become one of the most
severe HIV/AIDS epidemic areas in China [4,10]. Since
then, China has undergone an ever-growing increase in
HIV/AIDS prevalence, initially fuelled by IDUs. In 2001,
up to 66.5% of newly diagnosed HIV infections were re-
lated to drug use [11]. In order to constrain the dual ep-
idemics of HIV/AIDS and drug use, China has adopted
a methadone maintenance treatment program (MMTP)
[11]. The MMTP was initiated in early 2004 as a small
pilot project in just eight government-supported clinics
of five provinces, and subsequently expanded into a na-
tionwide program encompassing 738 clinics covering 27
provinces and serving some 344,254 drug users by the
end of 2011 [11,12]. Numerous studies reported the
HIV and HCV infection prevalence among MMTP cli-
ents in China, showing the large variations in preva-
lence of HIV and HCV infection in different geographic
locations. However, few studies have analyzed the geo-
graphic distribution patterns of HIV and HCV infec-
tions on a smaller scale (e.g., below county level) [12].
This type of analysis is needed to better understand be-
havioral and risk perception factors that may contribute
to infections. Advances in geographic statistical tech-
niques and geographical information systems (GIS) pro-
vide powerful tools that help characterize and improve
our understanding of the geographic distribution of
diseases [13].
This study aimed to characterize the geographic distri-
bution patterns of HIV and HCV infections among drug
users at the township level using GIS-based geographic
analyses involving geographic autocorrelation analysis
and geographic scan statistics. The high- or low preva-
lence areas of HIV-, HCV- and co-infections among drug
users were identified in a Yi Autonomous Prefecture,
Southwest of China, where a national MMTP has been
implemented since 2004. Knowledge of geographic distri-
bution patterns of HIV and HCV infections among drug
users has critical implications for future MMTP imple-
mentation and health policies regarding both HIV and
HCV prevention among drug users in China. These find-
ings will help aid the public health focus and better guide
the use of limited resources.
Methods
Study location and population
This study took place in the Yi Autonomous Prefecture,
Southwest of China, one of the most endemic areas of
HIV/AIDS in China. The geographic area is 6.04 × 106 ha
in size and has a population of 4.873 million. Approxi-
mately 50% of the population belongs to the Yi ethnic
group. The Yi Autonomous Prefecture consists of 618
townships, 16 counties and 1 city. The proportion of Yi
are more than 50% in 9 of 16 counties and more than 90%
in the I, M and R counties (Figure 1). In 2004, one of the
first eight national MMTP clinics was established in the
Prefecture [14]. By the end of 2012, there were 10 fixed
MMTP clinics and 1 mobile MMTP clinic. City A had two
fixed MMTP clinics and 1 mobile MMTP clinic (Figure 1).
All clients attending the 11 MMTP clinics of the Yi
Autonomous Prefecture from March 2004 to December
2012 were selected as our study population. Details on
the eligibility for participating in the national MMTP
were reported elsewhere [11,14,15]. Inclusion criteria
were: 1) Heroin users failing to quit drug use more than
once; 2) age ≥ 20 years; and 3) full civil capacity. All clients
in MMTP clinics were checked for HIV and HCV infec-
tions one month after entry into the MMTP [14,15].
Written informed consent was obtained from all clients.
Ethical approval for the MMTP was granted by the insti-
tutional review board of the National Center for AIDs/
STD Control and Prevention, China CDC.
Data collection and management
The demographic and clinical characteristics of all clients
in the 11 MMTP clinics of the Yi Autonomous Prefecture
from March 2004 to December 2012 were collected from
the database of the national MMTP [11]. The information
regarding HIV and HCV infections, gender, ethnicity, age,
drug use behaviors and address of the MMTP clients were
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used in the study. Data were entered in Microsoft Excel
version 2003 (Microsoft Corp., Redmond, WA). Indivi-
duals were considered infected with HIV or HCV if they
had one positive test result when they first entered into
the MMTP. Only the clients with the results of both HIV
or HCV infection and a current address were analyzed.
Statistical analysis
The characteristics and infection prevalence of the clients
were analyzed using the SPSS Statistical Package for Social
Sciences (SPSS Inc., Chicago, IL, 2007).
Geographic autocorrelation analysis
Geographic autocorrelation analysis was used to detect
significant differences from a random geographic distri-
bution of HIV infection, HCV infection, and HIV/HCV
co-infection. Moran’s I spatial autocorrelation statistics
were calculated and visualized in the form of Moran
Scatter Plots and Cluster Maps. In order to consider
variance instability of prevalence in both Global and
Local geographic autocorrelation analyses, the Empirical
Bayes (EB) adjustment for the variance instability of
infection prevalence was employed [16]. The geographic
weight files were created using Contiguity-Based Geo-
graphic Weights (Rook Criterion). A significance assess-
ment was performed by means of a permutation test, and
a reference distribution was generated under the assump-
tion that the prevalence was randomly distributed. In
order to obtain more robust results, the number of per-
mutation tests was set to 99999. Runs were carried out
until the results stabilized. The significant P-level was set
as 0.05. Both Global and Local geographic autocorrelation
analyses were implemented using Open Geoda 0 · 9 · 8 · 14
software (http://geodacenter.asu.edu/software). The Local
geographic autocorrelation analyses generated four geo-
graphic patterns including High-High, High-Low, Low-
High and Low-Low [13] A High-High pattern was one in
which a township and its surrounding townships collect-
ively had higher infection prevalence than the average in
the database. A Low-Low pattern was one in which a
township and its surrounding townships collectively had
below average infection prevalence. A High-Low pattern
was one in which a township had above average infection
prevalence, while its surrounding townships had below
average infection prevalence. A Low-High pattern was
one in which a township had below average infection
prevalence, but its surrounding townships had above
average infection prevalence.
Linear correlation analyses
Preliminary data analyses showed that the EB adjusted
prevalence of HIV-, HCV-, and co-infection was skewed,
so a square root transformation of the EB adjusted preva-
lence was performed. The linear correlations of the HIV-,
HCV- and co-infection EB adjusted prevalence across
townships were analyzed and the Pearson’s correlation
coefficient was calculated.
Geographic cluster analysis
Geographic scan statistics were employed to detect and
evaluate clusters with high or low prevalence of HIV,
HCV and HIV/HCV cases in purely geographic dimen-
sions. These were done by gradually scanning a circular
window across geography and noting the number of ob-
served and expected observations inside the window at
each location. The Bernoulli probability model for high
Figure 1 A map illustrating the location of the Yi Autonomous Prefecture in Southwest China and positions of the 11 MMTP clinics in
the Yi Autonomous Prefecture. The box shows the position of the Yi Autonomous Prefecture. The right enlarged map shows the geographic
positions of the 11 MMTP clinics and the distribution of the Yi ethnic group.
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or low prevalence was used. The maximum geographic
cluster size was set to 50% percent of the clients at risk
or not at risk [17,18]. Cases were defined as the MMTP
clients infected with HIV or HCV in a location. Controls
were the remainder of the MMTP clients at this loca-
tion. The location of cases and controls was defined as
the geographical coordinate (i.e., latitude/longitude) of
the center of the township in which they resided. Monte
Carlo hypothesis testing [19] was employed in this study
and the number of replications was set to 9999, with
significance at the 0.05 level. Geographic analyses were
carried out using the SaTScan™ v9 · 1 · 1 software (Kulldorff
M. and Information Management Services, Inc.) (http://
www.satscan.org/download.html).
A digitized polygon map was obtained for the Yi
Autonomous Prefecture at a scale of 1:250,000. Clusters
were mapped using ArcGIS 10.0software (Environmental
Systems Research Institute, Inc., Redlands, CA) in order
to identify their physical location.
Results
Demographic Characteristics and infection prevalence in
MMTP clients
A total of 6690 MMTP clients with both home address
and results of HIV or HCV testing from March 2004
through the end of 2012 were obtained from the data-
base of the 11 MMTP clinics (Table 1). 25.2% (1633 of
6488) were HIV infected and 30.8% (1735 of 5628) were
HCV infected. 10.9% (590 of 5426) were HIV/HCV co-
infected. Both the HIV infection (P < 0.0001) and HIV/
HCV co-infection (P = 0.004) prevalence in men were
higher than that in women. There was no significance
difference in HCV infection prevalence by gender. HIV
(P < 0.0001) and HCV (P = 0.027) infection and HIV/
Table 1 Demographic characteristics in patients with HIV infection, HCV infection and HIV/HCV co-infection at the
MMTP clients in Southwest China













Gender χ2 = 36.14, P < 0.0001 χ2 = 0.78, P = 0.378 χ2 = 8.29, P = 0.004
Female 928 17.2 866 32.1 825 8.0
Male 5560 26.5 4762 30.6 4601 11.4
Age (years) χtrend2 = 29.77, P < 0.0001 χtrend2 = 4.87, P = 0.027 χtrend2 = 9.56, P = 0.002
<30 2885 27.5 2452 31.0 2376 11.9
30- 2773 24.7 2445 32.3 2338 10.8
40- 740 20.1 654 26.2 635 8.5
≥50 90 6.7 77 18.2 77 2.6
Ethnicity χ2 = 186.89, P < 0.0001 χ2 = 198.53, P < 0.0001 χ2 = 31.28, P < 0.0001
Yi 5381 28.5 4492 26.5 4386 12.0
Han 1058 8.6 1089 48.2 997 5.9
Other 49 18.4 47 44.7 43 9.3
County (the proportion
of the Yi (%))
χtrend2 = 198.30, P < 0.0001 χtrend2 = 276.11, P < 0.0001 χtrend2 = 5.37, P = 0.021
<25 1072 10.7 1117 44.8 1011 7.1
25- 187 12.3 174 30.5 169 8.3
50- 1305 23.6 1244 44.0 1222 16.2
≥75 3824 30.9 2994 18.9 2925 10.2
Route of drug use χ2 = 426.07, P < 0.0001 χ2 = 334.83, P < 0.0001 χ2 = 199.43, P < 0.0001
Smoking or sniffing 4050 16.3 3589 22.1 3486.0 6.3
Pure injection 1114 36.5 984 48.3 910.0 18.5
Injection mixed with other 1413 40.6 1141 41.9 1115.0 18.6
Sharing syringes χ2 = 435.43, P < 0.0001 χ2 = 103.30, P < 0.0001 χ2 = 162.66, P < 0.0001
Yes 1176 49.1 1017 44.1 915 22.8
No 5312 19.9 4611 27.9 4511 8.4
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HCV (P = 0.002) co-infection prevalence of the MMTP
clients decreased with increasing age. There was a higher
prevalence of both HIV infection and HIV/HCV co-
infection in Yi patients than in Han patients (P < 0.0001).
The prevalence of HCV infection in Han patients was
higher than that of Yi patients (P < 0.0001). As the pro-
portion of Yi patients increased at the county-level,
both HIV infection (P < 0.0001) and HIV/HCV co-
infection (P = 0.021) prevalence in the MMTP clients
increased, while HCV infection prevalence decreased
(P <0.0001). MMTP clients that injected drugs or shared
syringes were more likely to be infected with HIV and
HCV than the MMTP clients who did not inject drugs or
share syringes (P < 0.0001) (Table 1). Multivariate logistic
regression analyses showed that age was not associated
with HIV infection prevalence (χ2wald = 1.19, P = 0.276) or
HIV/HCV (χ2wald = 0.72, P = 0.396) co-infection. Patient
gender was not related to HIV/HCV co-infection (χ2wald =
1.04, P = 0.308). Other characteristics were associated with
the two virus infections (P < 0.01).
Characteristics of drug users of different ethnicity
More than half of all drug users smoked or sniffed drugs.
The proportion of Han patients that only injected drugs
was higher than that of other ethnicities (χ2 = 258.61,
P < 0.0001). More than half of drug users did not share
syringes. The proportion of the Han patients sharing
syringes was higher than that of Yi patients (χ2 = 67.69
P < 0.0001) (Table 2).
Correlation of HIV-, HCV- and co-infection prevalence
There was a positive relationship between HIV and HCV
EB adjusted prevalence among drug users across the
townships (Pearson r = 0.263, P < 0.001), but the degree
of relationship was not high. There was a strong positive
relationship between HIV prevalence and HIV/HCV co-
infection prevalence (Pearson r = 0.683, P < 0.001), and
between HCV prevalence and HIV/HCV co-infection
prevalence (Pearson r = 0.615, P < 0.001).
Geographic cluster analysis of HIV infection
There were 396 townships with drug users tested for HIV
infection and 222 townships without drug users tested for
HIV infection. There was a significant Global geographic
autocorrelation for HIV infection. The EB Rate Moran’s I
was 0.3015 (P < 0.0001, 99999 permutations).
For high prevalence of HIV infection, the results of the
EB adjusted LISA (Local Indicators of Spatial Association)
cluster analysis was similar to the results of the geographic
scan cluster analysis (Figure 2). There were 37 High-
High townships distributed in the I, M, R and P counties
(Figure 2). The 37 High-High townships had 835cases
(more than one-half of the total 1633 cases). The HIV
infection prevalence of the drug users in these 37 town-
ships was 41.8% (835/1998). The 9 High-Low townships
had 45 cases and the infection prevalence of the drug
users in the 9 townships was 23.9% (45/188). Outside the
37 High-High and 9 High-Low townships, there were only
753 cases with a 17.5% (753/4312) infection prevalence. 3
significant geographic high risk clusters of HIV infection
were observed (P < 0.05) (Figure 2 and Table 3). These 3
clusters included 92 townships and 1122 cases (more than
two-thirds of the total 1633 cases), with a 38.1% infection
prevalence. Outside these 3 clusters, there were only
511 cases. The HIV infection prevalence of the drug
users outside of these 3 clusters was 14.4%.
For low prevalence of HIV infection, the results of local
geographic autocorrelation analyses showed that there
were 42 significant Low-Low townships which were not
located in the I, M, R and P counties. These townships
had only 63 cases, with a 7.5% (63/837) infection preva-
lence (Figure 2 and Table 3). The results of geographic
scan statistics showed that there were 2 low risk clusters,
which included 74 townships with a 7.2% (48/663) HIV
infection prevalence. Most of the 74 townships were not
Low-Low townships (Figure 2).
Geographic cluster analysis of HCV infection
There were 398 townships with drug users tested for
HCV infection and 220 townships without drug users
tested for HCV infection. There was a significant Global
Table 2 Characteristics of drug users among different ethnic groups
Yi Han Other
Number of clients Proportion (%) Number of clients Proportion (%) Number of clients Proportion (%)
Route of drug use χ2 = 258.61, P < 0.0001
Smoking or sniffing 3456 63.0 618 53.7 31 58.5
Pure injection 775 14.1 383 33.3 12 22.6
Injection mixed with other 1256 22.9 149 13.0 10 18.9
Sharing syringes χ2 = 84.56, P < 0.0001
Yes 939 17.1 317 27.6 22 41.5
No 4548 82.9 833 72.4 31 58.5
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geographic autocorrelation for HCV infection. The EB
Rate Moran’s I was 0.3449 (P < 0.0001, 99999 permuta-
tions). This result was similar to HIV infection, however,
the local geographic distribution pattern of HCV infec-
tion was different from that of HIV infection (Figure 2
and Figure 3).
For high prevalence of HCV infection, the local geo-
graphic autocorrelation analysis showed that there were
44 significant High-High townships. These were mainly
distributed in the A, C, E, P, Q and R counties (Figure 3).
These High-High townships included 718 cases, with
a 58.3% (718/1232) infection prevalence. Outside the
High-High townships, there were 1017cases, with a
23.1% (1017/4395) infection prevalence. The geographic
scan statistics identified 2 significant geographic high
clusters of HCV infection, which included 1127 cases
(approximately two-thirds of the total 1735) with a
49.9% (1127/2257) infection prevalence. Outside the
high clusters there were only 608 cases, with an 18.0%
(608/3370) infection prevalence (Figure 3 and Table 4).
For low prevalence of HCV infection, the local geo-
graphic autocorrelation analyses identified 44 significant
Low-Low townships which were mainly distributed in
the I and K counties (Figure 3). These Low-Low townships
had only 159 cases with a 9.7% (159/1631) infection
prevalence. The geographic scan statistics identified 1
significant geographic low cluster which included most
of the Low-Low townships (Figure 3). This low cluster
included 143 townships with a 13.0% (321/2460) infec-
tion prevalence.
Geographic cluster analysis of co-infection with HIV and
HCV
There were 389 townships with drug users tested for
both HIV and HCV infection. 229 townships without
drug users tested for HIV or HCV infection. There was
a significant Global geographic autocorrelation for HIV/
HCV co-infection. The EB Rate Moran’s I was 0.3155
(P < 0.0001, 99999 permutations). This result was similar
to both HIV and HCV infections (Figures 2, 3 and 4).
For high prevalence of HIV/HCV co-infection, the
local geographic autocorrelation analysis identified 26
High-High townships. These were mainly distributed in
the P and R counties. The 26 townships had 217 cases,
with a 37.2% HIV/HCV co-infection prevalence. The
geographic scan statistics analysis identified 1 significant
high cluster, which included most of the High-High town-
ships (Figure 4). This cluster had 323 cases (more than
one-half of the total 590 cases), with a 27.8% (323/1163)
HIV/HCV co-infection prevalence. Outside the cluster
there were only 267 cases, a 6.3% (267/4263) HIV/HCV
co-infection prevalence (Figure 4 and Table 5).
For low prevalence of HIV/HCV co-infection, the local
geographic autocorrelation analysis identified 41 signifi-
cant Low-Low townships. These were mainly distributed
in the I, K, O and N counties (Figure 4). These Low-Low
townships had only 12 cases, a 1.9% (12/623) HIV/HCV
co-infection prevalence. The geographic scan statistics
analysis identified 2 significant low clusters that included
198 townships (Figure 4 and Table 5). The 2 clusters had
141 cases, a 4.7% (141/2972) HIV/HCV co-infection
prevalence. Outside the clusters, there were 449 cases, an
18.3% (449/2454) HIV/HCV co-infection prevalence.
Figure 2 EB adjusted LISA cluster map and geographic scan
cluster locations of HIV infection among drug users in the
national MMTP in Southwest China at the township level. Red
circles represent high risk clusters and blue circles represent low risk
clusters.
Table 3 Cluster information for HIV infection among MMTP clients using the geographic scan statistic in Southwest
China
Type of cluster Number of towns Cluster center
(Latitude/longitude)







Most likely high risk cluster 80 27.9933 N, 102.8750 E 40.08 2714 1014 2.30 185.53 0.0001
Secondary high risk cluster 11 28.5176 N, 102.6218 E 11.46 201 89 1.81 18.00 0.0001
Secondary high risk cluster 1 28.8382 N, 102.7705 E 0.00 30 19 2.54 9.78 0.0289
Secondary low risk cluster 67 26.4770 N, 102.1328 E 114.25 394 23 0.22 53.92 0.0001
Secondary low risk cluster 7 29.0614 N, 102.7907 E 10.09 269 25 0.36 22.68 0.0001
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Discussion
The Yi Autonomous Prefecture is one of the largest
illicit drug production and distribution centers of China.
It is located along one of the main drug trafficking
routes from the ‘Golden Triangle’ to northwest and cen-
tral China [20]. The Prefecture has experienced an alarm-
ing increase in HIV infections since the first HIV case was
identified among drug users in M county in 1995. This
HIV epidemic has spread to all 16 counties and 1 city [20].
By the end of 2011, the cumulative number of individuals
infected with HIV was over 25,000 [21]. We found the
prevalence of HIV-, HCV- and co-infection were corre-
lated across townships, similar to the previous reports
[22-24]. The degree of relationship between HIV and
HCV was not high. Our results from both the geographic
autocorrelation analysis and the geographic scan statistical
analysis showed that HIV-, HCV-, and co-infections in the
Prefecture all exhibited significant geographic clustering at
the township level. The geographic distribution patterns
of these infections were clearly different. The areas of high
HIV infection prevalence were mainly in the I, M, R and P
counties where the proportion of Yi ethnic group was
more than 50%. High HCV infection prevalence mainly
occurred in the A, C, E, P, Q and R counties. Of these 6
counties, 3 (A, C, E) had a proportion of Yi population less
than 50%. The high prevalence of co-infection with HIV
and HCV mainly occurred in the P and R counties. These
findings indicate that there might be some isolation of
these communities, with more spread of infection within
the communities than between them. The geographic het-
erogeneity of the two virus infections might be related to
the geographic distribution of the ethnic groups involved.
Our results revealed that HIV infection prevalence of the
MMTP clients increased gradually, while HCV infection
prevalence decreased gradually, as the proportion of Yi
increased at the county level. This might be related to the
special cultural traditions of the Yi ethnic group and the
low proportion of the Yi injecting drug use or sharing
syringes compared to the Han. This Yi ethnic minority still
maintains traditional social norms and values including
arranged marriage between members of the same social
status and condoned causal sex. Hence, the transmission
of these infections might be easier within some Yi com-
munities than between them. Casual sex is also more fre-
quent among Yi males than Han males, and unmarried Yi
females have more frequent casual sexual behavior than
married Yi females. Furthermore, condom use occurs in-
frequently among the Yi ethnic group [20,25]. More than
86% of the MMTP clients were less than 40 year old, so
heterosexual transmission was more frequent among the
Yi ethnic group than among the Han ethnic group. We
also found that the proportion of Han both injecting drug
and sharing syringes was higher than that of the Yi. Al-
though HIV and HCV share routes of transmission, HCV
is most efficiently transmitted via exposure to contami-
nated blood. For example, the transmission efficiency of
HCV has been estimated to be some 10 times greater than
that of HIV for needle-stick injuries, while the sexual and
perinatal transmission of HCV is inefficient [1,9,26,27]. In
A City with an 81.2% Han ethnic group, the HCV antibody
prevalence among IDUs infected with HIV was 81.3% and
the HIV/HCV prevalence ratio within the IDU population
was 0.3. According to Vickerman et al. (2013) [28], the
median estimated percentage of existing HIV infections
due to sexual HIV transmission was only 38% in A city. In
M County with a 97.1% Yi ethnic group, the HCV
Table 4 Cluster information for HCV infections among drug users, using the geographic scan statistic in Southwest
China
Type of cluster Number
of towns
Coordinates Radius (Km) Population Number
of cases
Relative risk Log likelihood ratio P value
Most likely low risk cluster 143 27.3696 N, 102.8758 E 78.64 2460 321 0.29 346.71 0.0001
Secondary high risk cluster 97 28.5478 N, 102.9428 E 55.73 1505 721 1.95 134.41 0.0001
Secondary high risk cluster 23 27.9769 N, 102.1250 E 19.14 752 406 1.98 101.19 0.0001
Figure 3 EB adjusted LISA cluster map and geographic scan
cluster location of HCV infection among drug users in the
national methadone maintenance treatment program in
Southwest China at the township level. Red circles represent high
risk clusters and blue circles represent low risk clusters.
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prevalence among IDUs infected with HIV was 57.5% and
the HIV/HCV prevalence ratio within the IDU population
was 1.3. Thus, the median estimated percentage of existing
HIV infections due to sexual HIV transmission was 88%
[28]. High HIV infection prevalence was more inclined to
appear in some Yi cluster communities, while high HCV
infection appeared in both Han cluster communities and
Yi cluster communities.
Due to the shared routes of transmission, co-infection
with HIV and HCV was very common in IDUs [1]. The
HIV/AIDS epidemic in the Yi Prefecture was initially
driven by transmission via injection drug use, and the
majority of the early reported HIV cases occurred in
young adults infected by injection drug use [20,25].
Among the 4 counties (I, M, R and P) with a high preva-
lence of HIV infection, the areas of high prevalence of co-
infection with HIV and HCV were the P and R counties.
County I had a low prevalence of co-infection with HIV
and HCV. One reason for the substantial geographic het-
erogeneity in co-infection with HIV and HCV may be the
difference in drug use behaviors between the two regions.
The proportion of IDUs among the MMTP clients was
64.5% in R County and 52.1% in P County, but only 39.4%
in I county. The other reason for this heterogeneity may
be the difference in sexual HIV transmission between the
two regions. The HCV antibody prevalence among IDUs
infected with HIV was 86.7% in P County and 83.7 in R
County. The HIV/HCV prevalence ratio within the IDU
population was 0.64 in P County and 0.90 in R County.
The median estimated percentage of existing HIV infec-
tions due to sexual HIV transmission was 55% in P
County and 67% in R County [28]. However, in I County,
the HCV prevalence among IDUs infected with HIV was
12.9% and the HIV/HCV prevalence ratio within the IDU
population was 5.1. The median estimated percentage of
existing HIV infections due to sexual HIV transmission
was 88% [28]. These findings imply that intravenous drug
use and heterosexual intercourse might be two important
transmission routes in both P and R Counties, whereas in
I county, heterosexual intercourse might be the dominate
transmission route. The route of transmission in I county
might be reflective of a change in the route of transmis-
sion from intravenous drug use to heterosexual sex. This
needs further study. Analysis of surveillance data from the
Yi Autonomous Prefecture showed that, over time, the
percentage of intravenous drug use accounting for HIV
transmission decreased, while transmission by heterosex-
ual intercourse increased [29].
Our findings of substantial geographic heterogeneity
of HIV and HCV infections at the township level imply
that it is may be necessary to inform or invent site-
specific intervention strategies to address the special cul-
tural traditions of the Yi ethnic group in endemic areas
and to better allocate currently limited resources to
combat these two viruses. For example, P and R Coun-
ties have a high prevalence of co-infection with HIV and
HCV. Because HIV/HCV co-infection in IDUs has be-
come a rapidly emerging global public health problem
[30,31], multiple approaches are imperative to prevent
both HIV and HCV infections, identify new cases, and
provide care. Local MMTP clinics should be strength-
ened and expanded using local multi-sector cooperation
(e.g., public security and public heath sectors) to in-
crease the coverage and retention of MMTP and im-
prove accessibility of services [11]. Thus, more drug
users will be engaged in the MMTP clinics and receive
Table 5 Cluster information for HIV/HCV co-infection among MMTP clients, using the geographic scan statistic in
Southwest China
Type of cluster Number
of towns
Coordinates Radius (Km) Population Number
of cases
Relative risk Log likelihood ratio P value
Most likely high risk cluster 92 28.5087 N, 103.0829 E 55.71 1163 323 4.43 180.48 0.0001
Secondary low risk cluster 163 27.2293 N, 102.8077 E 88.14 2710 134 0.29 103.25 0.0001
Secondary low risk cluster 35 28.3288 N, 101.9280 E 46.04 262 7 0.24 13.08 0.0016
Figure 4 EB adjusted LISA cluster map and geographic scan
cluster locations of HIV/HCV co-infection among drug users in
the national MMTP in Southwest China at the township level.
Red circles represent high risk clusters and blue circles represent low
risk clusters.
Zhou et al. BMC Infectious Diseases 2014, 14:134 Page 8 of 10
http://www.biomedcentral.com/1471-2334/14/134
more effective interventions, including uninterrupted
drug substitution treatments, and both HIV and HCV
testing. Effective prevention and treatment for both
infections will be available and provide an ability to halt
the tide of increasing morbidity and mortality due to
HCV/HIV-related disease.
There are some limitations to our study. First, only a
part of all the drug users enrolled in the MMTP clinics. It
is difficult to confirm whether MMTP participants are a
truly representative sample of a population of community-
dwelling drug users. However, it has been estimated that
the national HIV prevalence among MMTP clients is not
significantly different from that among non-MMTP drug
users reported by national sentinel surveillance during
2004–2009 [12]. Second, HIV and HCV are transmissible
infections, and they often share similar transmission
routes. Therefore, the clustering found with the spatial
methods might be related to the clustering of risk behav-
iors, to natural geographic boundaries between human
populations, or to both. However, due to the limitations of
these analytic approaches (e.g., they did not consider HIV,
HCV and co-infections as communicable diseases, and are
limited in the ability to identify which reason may contrib-
ute to the clustering), we cannot analyze unambiguously
what resulted in the clustering. In addition, the infor-
mation regarding the use of condoms and sexual behav-
iors is not available and individual risk factors were not
considered in the framework of our geographic analyses.
These limit the ability to further analyze why the geo-
graphic distribution of these infections in our study field
was heterogeneous. Some studies show that casual
sexual behaviors are frequent, and condoms were infre-
quently used among the Yi ethnic group compared to
the Han ethnic group [20,25].
Conclusions
This was the first study to analyze the geographic distri-
bution patterns of HIV-, HCV, and co-infections among
drug users in a national MMTP in a Yi Autonomous
Prefecture, Southwest of China. These infections exhib-
ited substantial geographic heterogeneity at the township
level. Their geographic distribution patterns were also
obviously different. These findings imply that it is may
be necessary to inform or invent specific intervention
strategies, particularly regarding the Yi ethnic group.
Currently limited resources will need to be reallocated
according to these findings.
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